Product Images Padcev Ejfv
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Padcev Ejfv NDC 51144-020 by Seagen Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Enfortumab vedotin structural formula - image 01
The provided text is not-available.*
Padcev (enfortumab vedotin-ejfv) for injection 20 mg/vial label - image 02
Each vial of PADCEV contains 20 mg of enfortumab for intravenous infusion only. It is recommended to store the vial refrigerated and not to shake it before use. The vial also contains histidine and trademarks are jointly owned by Sezgn and PADCEV. The potency standard is not regulated by the US. Other information on this document is not legible.*
Padcev (enfortumab vedotin-ejfv) for injection 30 mg/vial label - image 03
PADCEV is a cytotoxic agent that is administered through intravenous infusion after reconstitution and dilution. Each single-dose vial contains 30 mg of enfortumab vedotin and should be discarded after use. A caution against cytotoxicity is issued on the label because the medication can be harmful. Furthermore, there is a warning that the medication is destroyed when frozen, so storing it between 36°F and 46°F (2°C to 8°C) is advised. Agensys, Inc., and Seagen Inc. own PADCEV and the PADCEV device trademarks.*
image 04
image 05
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.